Presentation is loading. Please wait.

Presentation is loading. Please wait.

BRAF inhibitor-resistant BRAF-mutant melanoma cells show increased invasion and metastatic potential. BRAF inhibitor-resistant BRAF-mutant melanoma cells.

Published byMarie-Christine Anne-Sophie Lheureux Modified over 5 years ago

Similar presentations

Presentation on theme: "BRAF inhibitor-resistant BRAF-mutant melanoma cells show increased invasion and metastatic potential. BRAF inhibitor-resistant BRAF-mutant melanoma cells."— Presentation transcript:

1 BRAF inhibitor-resistant BRAF-mutant melanoma cells show increased invasion and metastatic potential. BRAF inhibitor-resistant BRAF-mutant melanoma cells show increased invasion and metastatic potential. A, in vitro invasion of A375, A375/R, A375(X), A375(X)/R, Colo829, and Colo829/R cells into collagen I matrices. Data are representative of 3 independent experiments, with error bars to indicate SE. *, P < 0.05; **, P < 0.01; ***, P < B, protein interaction network showing 91 differentially expressed phosphoproteins from the cytoskeleton cluster in A375 and A375/R cells. The network was generated using STRING (23). Color coding is used to show evidence for the types of interactions between the individual phospho-proteins. C, quantification of the tumor area in the lungs of mice following tail vein injection with A375(X) or A375(X)/R cells. D, invasion of A375/R, A375(X)/R, and Colo829/R cells in the presence of DMSO, gefitinib (2 μmol/L), and dasatinib (10 nmol/L). Data are representative of 3 replicates from 3 independent experiments, with error bars to indicate SE. *, P < 0.05; **, P < E, invasion of A375/R, A375(X)/R, and Colo829/R cells transfected with scrambled control (SC), SRC (siSRC), or LYN (siLYN) siRNA. Data are representative of 3 replicates from 3 independent experiments, with error bars to indicate SE. *, P < 0.05; **, P < Western blots show SRC and LYN expression. Tubulin: loading control. F, quantitation of phospho-array data for STAT family members in Fig. 2A. G, Western blot analyses for phosphorylated STAT3 (pSTAT3) and STAT3 (loading control) in A375, A375/R, A375(X), A375(X)/R, Colo829, and Colo829/R cells. H, Western blot analyses for phosphorylated STAT3 (pSTAT3) and STAT3 (loading control) in A375(X)/R cells treated with DMSO, gefitinib (GEF; 2 μmol/L), dasatinib (DAS; 10 nmol/L), the JAK3 inhibitor P6 (JAK3i; 2 μmol/L), PLX4720 (PLX; 2 μmol/L), and S3I-201 (20 μmol/L). I, A375/R cell invasion in the presence of DMSO or S3I-201 (50 μmol/L). Data are representative of 3 independent experiments, with error bars to indicate SE. *, P < 0.05; **, P < 0.01. Maria R. Girotti et al. Cancer Discovery 2013;3: ©2013 by American Association for Cancer Research

Download ppt "BRAF inhibitor-resistant BRAF-mutant melanoma cells show increased invasion and metastatic potential. BRAF inhibitor-resistant BRAF-mutant melanoma cells."

Similar presentations

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines  Jie.

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines  Jie.
EMT correlates with PERK but not IRE1 signaling in primary human tumors. EMT correlates with PERK but not IRE1 signaling in primary human tumors. A, two.

EMT correlates with PERK but not IRE1 signaling in primary human tumors. EMT correlates with PERK but not IRE1 signaling in primary human tumors. A, two.
Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.

Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.
Type VIIa1 collagen and laminin-γ2 promote a p53 mutant/HIF-1–dependent proinvasive phenotype. Type VIIa1 collagen and laminin-γ2 promote a p53 mutant/HIF-1–dependent.

Type VIIa1 collagen and laminin-γ2 promote a p53 mutant/HIF-1–dependent proinvasive phenotype. Type VIIa1 collagen and laminin-γ2 promote a p53 mutant/HIF-1–dependent.
Volume 21, Issue 6, Pages (June 2012)

Volume 21, Issue 6, Pages (June 2012)
Volume 19, Issue 1, Pages (January 2011)

Volume 19, Issue 1, Pages (January 2011)
Altered interferon signaling with JAK1 loss-of-function mutation in M431 and interferon gamma-inducible PD-L1 expression by 48 melanoma cell lines. Altered.

Altered interferon signaling with JAK1 loss-of-function mutation in M431 and interferon gamma-inducible PD-L1 expression by 48 melanoma cell lines. Altered.
BET inhibition and depletion repress the expression of BRCA1 and RAD51

BET inhibition and depletion repress the expression of BRCA1 and RAD51
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
PDGFRβ is dispensable for EGFRvIII-driven GBM growth but is required for the optimal growth of EGFR-inhibited tumors. PDGFRβ is dispensable for EGFRvIII-driven.

PDGFRβ is dispensable for EGFRvIII-driven GBM growth but is required for the optimal growth of EGFR-inhibited tumors. PDGFRβ is dispensable for EGFRvIII-driven.
CHK1 downregulation upon ERG overexpression.

CHK1 downregulation upon ERG overexpression.
A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.

A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.
The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.

The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.
COX-2–PGE2 signaling is required for MSC-induced increase in ALDHhigh CSC-enriched population and tumor initiation. COX-2–PGE2 signaling is required for.

COX-2–PGE2 signaling is required for MSC-induced increase in ALDHhigh CSC-enriched population and tumor initiation. COX-2–PGE2 signaling is required for.
Volume 20, Issue 6, Pages (December 2011)

Volume 20, Issue 6, Pages (December 2011)
Fig. 2 Fas controls IL-1RA–sEV secretion in murine MSCs.

Fig. 2 Fas controls IL-1RA–sEV secretion in murine MSCs.
Interaction networks of the regulated phosphoproteins.

Interaction networks of the regulated phosphoproteins.
Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.

Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.
Regulated P124SMEK1 expression cannot alter p-ERK levels or sensitivity to BRAF or MEK inhibition in V600EBRAF melanoma cell lines. Regulated P124SMEK1.

Regulated P124SMEK1 expression cannot alter p-ERK levels or sensitivity to BRAF or MEK inhibition in V600EBRAF melanoma cell lines. Regulated P124SMEK1.
EGFR is intrinsically active in FGFR3-activated cell lines with combination efficacy from targeting both EGFR and FGFR3. EGFR is intrinsically active in.

EGFR is intrinsically active in FGFR3-activated cell lines with combination efficacy from targeting both EGFR and FGFR3. EGFR is intrinsically active in.

Similar presentations

Ads by Google